Uncategorized
Imprimis reports $4.6 million net loss in second quarter
Imprimis Pharmaceuticals reported a net loss of $4.6 million, or $0.35 per common share, in the second quarter compared with a net loss of $3.7 million, or $0.39 per common share, in the second quarter of 2015, according to a press release.Total revenue in the second quarter was $4.9 million, a nearly 150% increase from approximately $2 million a year ago. Ophthalmology-related revenue totaled $2.6 million, an increase of more than 330%.